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K. Donovan*University Hospital of Wales, Cardiff, UKThe native arterio-venous fistula provides the best access for haemodialysis. The dialysis population is growing in number,
becoming more elderly, and has increasingly complex medical co-morbidity. The ability to establish and maintain optimal
haemodialysis access in this population requires the planning and commissioning of operating and diagnostic facilities and
the training of sufficient suitable surgical specialists. This article outlines the major factors that influence the demand for and
requirements of a vascular access service for the renal failure population.Keywords: Dialysis; Vascular access; Demography.Introduction
The delivery of good haemodialysis with adequate
clearance of harmful accumulating solutes is funda-
mentally dependent on the quality of access to a
patient’s circulatory system. This must be reliably and
repeatedly accessible, should provide high blood flow
rates, and have low complication rates. Published
evidence, national guidelines, and current pro-
fessional opinion are all agreed that the gold standard
to achieve good access is the native arterio-venous
fistula (AVF). Since, Brescia and Cimino first described
a novel and reliable method of an AVF formation,1
numerous variations and adaptations have evolved,
and the provision and maintenance of the many types
of vascular access has become a complex, multi-
disciplinary sub-specialty in its own right.
To assess population requirements for access
surgery a number of interrelated variables need
consideration:
† The number of new (incident) patients.
† The size of the stock of patients who are on dialysis
or with transplants (prevalence).
† The co-morbidity of patients.
† The type of access desired.enal Access and Transplantation—one of a series of
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† Audit of performance against these standards.
The Dialysis Population—The Size of the Problem
The number of patients requiring dialysis is growing
across the developed and developing world, though at
quite different rates.2–4 In the UK overall growth of the
prevalent dialysis population is 5% per annum but as
much as 8% per annum for haemodialysis.3 There is a
dynamic relationship between incidence, transplant
rate/success and overall mortality that determines the
prevalent population on dialysis (Fig. 1) and ulti-
mately determines the crude numbers of patients
requiring access surgery. However, there are a number
of other factors that could also influence the demands
on surgery and the types of access offered:
† Patient age/co-morbidity
Patients accepted for dialysis are increasingly
elderly and with co-morbidities such as vascular
diseases and malignancies. Such patients tend to
require more support during their treatment and so
tend to default to supervised haemodialysis facilities.
In patients with severe co-morbidity, poor vessels, or
who have a limited prognosis, creation of an AVF may
be neither possible nor appropriate.
† Diabetes
Type II diabetes mellitus is now the commonest
cause of renal failure in the Western world2,4 and isEur J Vasc Endovasc Surg 31, 176–180 (2006)
doi:10.1016/j.ejvs.2005.10.001, available online at http://www.sciencedirect.com onved.
Fig. 1. Dynamic relationship between new (incident—red)
patients and modes of renal replacement therapy in
established (prevalent—blue) patients in the renal failure
population.
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blems. The outcome of AVFs created in patients with
diabetes is worse than those in non-diabetics,5 creating
more subsequent work in the form of revision surgery
and/or interventional radiology.
† Modality choice
Generally, about 60–70% of patients choose haemo-
dialysis as their treatment modality and, therefore,
require vascular access.2,4 In countries with a high
proportion of peritoneal dialysis (PD) vascular access
load is less, as was the case in the UK in the 80’s and early
90’s. More recently haemodialysis proportions in the UK
have increased in line with the rest of Europe.2,3 Despite
advances in technology, PD still has a comparatively
limited treatment lifetime, averaging around 2–3 years
after which HD is the only remaining therapy mode in
the absence of a transplant.
† Late presenters
There is a significant tranche of patients who
require urgent dialysis within weeks or days of
presentation. Such late presenters comprise about
15–30% of all new patients, and are important for
several reasons:6 firstly, they start dialysis with
temporary catheters which has been shown to
compromise future AVF survival;7 secondly, they
have had no time for formal education or information
about dialysis options and they are much more likely
to opt for haemodialysis as long term treatment;
thirdly, there will be a delay in providing permanent
access due to their immediate instability, the wait for
them to make a modality choice and subsequent
delays in operation and maturation. These patients
are intensive consumers of resource and they have a
much worse outcome than patients who have been
through the low clearance renal education system
with planned and established access.† Access patency
Vascular access that is unreliable, troublesome, or
prone to thrombosis or infection will inevitably create
more work increase hospitalisation, and may result in
inadequate dialysis and associated medical problems.8
The establishment of timely, reliable vascular access
from the outset reduces the subsequent access work-
load. Surveillance and early intervention when access
fails to mature or if function becomes problematic may
obviate the need for repeat operations.9
The combination of primary choice of dialysis mode,
the preferences of late presenters, the relatively limited
lifespan of PD as a treatment, the co-morbidity and
dependence of the dialysis population, and the dearth
of organ donors for transplantation inevitably increases
pressure on in-centre haemodialysis capacity and
vascular access surgery provision.What is Best?
Both the numbers and types operations required will
influence the shape of a vascular access service for the
renal failure population. There is general agreement
that, where possible, a native AVF should be the first
choice.3,10 Despite higher primary failure rates, reduced
secondary failures of autologous fistulae ensure
improved success over prosthetic fistulae or permanent
central lines.7 Once matured, patency at 5 years is about
50%.11,12 Primary failure rates are influenced by the site
of AVF creation; the use of more distal veins, age,
obesity, diabetes, vascular disease,5 a history of
previous failure or a vein diameter of !2 mm.13 Higher
risk patients may warrant a more thorough pre
operative assessment using Doppler mapping and
more frequent post-operative assessment to ensure
satisfactory fistula maturation.14 Surgical and radio-
logical intervention may improve outcome in proble-
matic AVFs.9 Autologous fistulae have fewer
complications than prosthetic grafts with 2–5 times
lower infection rates15,16 4 times lower thrombosis rates
and 3 times lower reintervention rates.17
Prosthetic AV grafts, using native harvested veins or
synthetic materials such as PTFE, offer an alternative
sealed subcutaneous access in patients with unsuitable
veins which is clearly superior to tunnelled lines but
inferior to autologous AV fistulae in terms of survival
and complication rates.7
Tunnelled lines have the advantage of providing
immediate access and they may be used when an AVF
or graft is contraindicated, technically impossible or
refused, but in other respects they are inferior to native
AVFs and grafts. The commonest reasons for failure ofEur J Vasc Endovasc Surg Vol 31, 2 2006
Table 1. Summary data from the DOPPS I study showing
achievements in vascular access provision in Europe and the
USA for incident and prevalent patients
Incident patients Prevalent patients
Europe USA Europe USA
AVF 66 15 80 24
CVC 31 60 8 17





K. Donovan178tunnelled lines are infection, with bacteraemia occur-
ring at about 2 per 1000 catheter days,18,19 and poor
blood flow (!300 ml/min), which occurs at least once
during the life of a catheter in almost 90% of patients.20
Medical practice is increasingly driven by protocols
and evidence based targets. In the UK the Renal
Association has outlined minimum standards against
which most units are now audited by electronic data
returned to the UK Renal Registry21 but as yet no data
about vascular access has been recorded or analysed.
The UK Renal Association targets for access21 are
similar to those already achieved across Western
Europe in the DOPPS I study.7 They state that 67%
planned patients should start dialysis with an AVF; that
80% of prevalent patients have a functioning AVF, and
that once referred to a surgeon, no patient should wait
for O4 weeks for an AVF.
The National Kidney Foundation Kidney Disease
Outcomes Quality Initiative (NKF-K/DOQI) rec-
ommendations for vascular access are that an AVF
should be used in 40% of prevalent and 50% of incident
patients. Catheters should be used in 10% of prevalent
patients. The suggested order of access preference is for
a radio-cephalic AVF, then brachio-cephalic, followed
by a synthetic graft, brachio-basilic transposition and
finally a tunnelled line.10What are We Actually Doing?
Accurate data from around the world provide useful
insights into the patterns of provision of vascular
access. Many countries and regions have reliable
databases that greatly facilitate audit and allow
observation of changes of practice. These include the
USRDS, ANZDATA, ERA-EDTA and UK Renal Reg-
istry. The Dialysis Outcomes and Patterns Practice
Study (DOPPS) I and II are landmark, longitudinal,
prospective studies of dialysis practice based on
standardised information collection. The original
study, started in 1996, included data from 17,000
patients in over 300 facilities in Germany, UK, Japan,
France, Spain and the USA. DOPPS II was started in
2002, included patients from the original cohort of
countries and added others from Australia, Belgium,
New Zealand and Sweden.
It is clear that there are widely disparate patterns of
vascular access. For example, pooled data from the
European countries involved showed that all, with the
exception of the UK, achieved and exceeded the UK
Renal Association Standards (Table 1). Despite the
recommendations of NKF-K/DOQI, the pattern of
practice in the USA differs markedly from that in
Europe and Japan and it has been suggested that this isEur J Vasc Endovasc Surg Vol 31, 2 2006a result of different co-morbidities.7,22 Nevertheless
there is some encouraging evidence that the NKF-
K/DOQI suggestions and targets are altering practice
and improving the prevalence of AVFs in the USA.23What is Needed Now and in the Future?
Estimates of the access workload required to meet
European targets are based on experience over a
number of years in large centres. In 2001, the UK
Kidney Alliance suggested that one operating session
was required per 120 patients on dialysis. This was
based on observations in several large UK centres
where they estimated that there would be 100 AVFs, 50
PD catheter insertions, 100 tunnelled lines and 400
temporary lines per million population served by a
unit.24 This model assumes current UK demography,
workloads and practice. As HD prevalence rises and
there is a shift towards permanent AV fistulae from
temporary lines then the number of AVF related
procedures would need to increase.
Data from one unit in South Wales, where the
prevalence of AVF is above the UK average at 80%C,
used a model based on the incidence and prevalence
rates/2 to estimate the number of access procedures
necessary.25 Using the latest UK data suggesting an
annual dialysis incidence of 100 per million and a
dialysis prevalence of 350 per million, the model
predicts the need for 200 surgical procedures per
million population per annum, of which about w65%
would be AVF related. As both incidence and
prevalence continue to rise the requirements will also
grow.
Models of care to enable the delivery of this service
will vary according to local surgical expertise, theatre
space and interventional radiological support. Nephrol-
ogy services should identify the size and complexity of
their vascular access requirements and commission
expertise and resources accordingly. In some countries,
including the UK, over-reliance on the small pockets of
expertise concentrated in large transplant centres has
resulted in under-investment in the many new dialysis
Population Requirements for Vascular Access Surgery 179units who may lack local expertise, and as a result, fail
to meet the minimum standards. The challenge is to
address this deficit in resource and plan for the future.
A number of models of service delivery have been
suggested including the building of separate specialist
access units or even mobile access theatres; the
development of vascular surgical networks with renal
centres, and the establishment of renal support as a core
element in future vascular surgical appointments. The
Vascular Society of Great Britain and Northern Ireland
has recognised this important need and has encouraged
training in renal access work by vascular surgical
trainees.Conclusions
The establishment of reliable vascular access for
haemodialysis patients is critical to their future care
and outcome. Where possible, a native AVF should
be created and maintained by dedicated access or
vascular surgeons and interventional radiologists.
Demand for these procedures is increasing due to
the rise in demand for dialysis and the increasing
complexity of the patients. Current suggested guide-
lines and targets are not met consistently and to do
so will require significant investment in skilled
personnel and supporting facilities. Identification
and characterisation of the population requirements
is essential to give an indication of the resources
needed, though the precise model through which to
deliver the care is still undecided. Increasing the
expertise in vascular access within vascular surgical
training and raising the profile of this life enhancing
subspecialty is a ‘sine qua non’.Summary
† Establishment and maintenance of reliable vascular
access is key to the success of haemodialysis.
† The native arteriovenous fistula is the gold standard.
† Demand for primary access and revision surgery
will grow as numbers and complexity of patients on
dialysis continue to increase.
† International audit shows diversity in the provision
and patterns of access surgery.
† Models to enable estimates of the number of
procedures required and regular audit should
facilitate the planning and allocation of resource
and skills.
† Investment in vascular surgical training, operating
facilities, and interventional radiology is required to
address current shortfalls and future demand.References
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